Table 1. Cardiovascular Drug-Eluting Stents(DES) Consumption Value & CAGR: China VS Global, 2018-2029, US$ Million

Table 2. Cardiovascular Drug-Eluting Stents(DES) Market Restraints

Table 3. Cardiovascular Drug-Eluting Stents(DES) Market Trends

Table 4. Cardiovascular Drug-Eluting Stents(DES) Industry Policy

Table 5. Global Cardiovascular Drug-Eluting Stents(DES) Revenue by Company, 2018-2023, US$ million, Ranked Based on Revenue in 2022

Table 6. Global Cardiovascular Drug-Eluting Stents(DES) Revenue Share by Company, 2018-2023, Ranked by Data of 2022

Table 7. Global Cardiovascular Drug-Eluting Stents(DES) Sales Quantity by Company, (2018-2023) & (K Units), Ranked Based on Sales in 2022

Table 8. Global Cardiovascular Drug-Eluting Stents(DES) Sales Quantity by Company, 2018-2023, Ranked by Data of 2022

Table 9. Global Cardiovascular Drug-Eluting Stents(DES) Average Selling Price (ASP) by Company, (2018-2023) & (US$/Unit)

Table 10. Global Cardiovascular Drug-Eluting Stents(DES) Manufacturers Market Concentration Ratio (CR3 and HHI)

Table 11. Global Cardiovascular Drug-Eluting Stents(DES) Mergers & Acquisitions, Expansion Plans

Table 12. Global Cardiovascular Drug-Eluting Stents(DES) Manufacturers Product Type

Table 13. Head Office and Cardiovascular Drug-Eluting Stents(DES) Production Site of Key Manufacturer

Table 14. Cardiovascular Drug-Eluting Stents(DES) Capacity of Major Manufacturers and Future Plan

Table 15. China Cardiovascular Drug-Eluting Stents(DES) Revenue by Company, 2018-2023, US$ million, Ranked Based on Revenue in 2022

Table 16. China Cardiovascular Drug-Eluting Stents(DES) Sales Quantity by Company, (2018-2023) & (K Units), Ranked Based on Sales in 2022

Table 17. China Cardiovascular Drug-Eluting Stents(DES) Sales Quantity by Company, 2018-2023, Ranked by Data of 2022

Table 18. Global Cardiovascular Drug-Eluting Stents(DES) Production & Forecast by Region, 2018 VS 2022 VS 2029, (K Units)

Table 19. Global Cardiovascular Drug-Eluting Stents(DES) Production by Region, 2018-2023, (K Units)

Table 20. Global Cardiovascular Drug-Eluting Stents(DES) Production Forecast by Region, 2024-2029, (K Units)

Table 21. Global Key Players of Cardiovascular Drug-Eluting Stents(DES) Upstream (Raw Materials)

Table 22. Global Cardiovascular Drug-Eluting Stents(DES) Typical Customers

Table 23. Cardiovascular Drug-Eluting Stents(DES) Typical Distributors

Table 24. By Type, Global Cardiovascular Drug-Eluting Stents(DES) Consumption Value & CAGR, 2018 VS 2022 VS 2029, US$ Million

Table 25. By Application, Global Cardiovascular Drug-Eluting Stents(DES) Consumption Value & CAGR, 2018 VS 2022 VS 2029, US$ Million

Table 26. By Region, Global Cardiovascular Drug-Eluting Stents(DES) Consumption Value, 2018 VS 2022 VS 2029, US$ Million

Table 27. By Region, Global Cardiovascular Drug-Eluting Stents(DES) Consumption Value, 2018-2029, US$ Million

Table 28. By Region, Global Cardiovascular Drug-Eluting Stents(DES) Sales Quantity, 2018-2029, (K Units)

Table 29. By Country, Global Cardiovascular Drug-Eluting Stents(DES) Consumption Value & CAGR, 2018 VS 2022 VS 2029, US$ Million

Table 30. By Country, Global Cardiovascular Drug-Eluting Stents(DES) Consumption Value, 2018-2029, US$ Million

Table 31. By Country, Global Cardiovascular Drug-Eluting Stents(DES) Consumption Value Market Share, 2018-2029

Table 32. By Country, Global Cardiovascular Drug-Eluting Stents(DES) Sales Quantity, 2018-2029, (K Units)

Table 33. By Country, Global Cardiovascular Drug-Eluting Stents(DES) Sales Quantity Market Share, 2018-2029

Table 34. MIV Therapeutics Company Information, Head Office, Market Area, and Industry Position

Table 35. MIV Therapeutics Cardiovascular Drug-Eluting Stents(DES) Models, Specifications, and Application

Table 36. MIV Therapeutics Cardiovascular Drug-Eluting Stents(DES) Sales Quantity (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin, 2018-2023

Table 37. MIV Therapeutics Company Profile and Main Business

Table 38. MIV Therapeutics Recent Developments

Table 39. Orbusneich Company Information, Head Office, Market Area, and Industry Position

Table 40. Orbusneich Cardiovascular Drug-Eluting Stents(DES) Models, Specifications, and Application

Table 41. Orbusneich Cardiovascular Drug-Eluting Stents(DES) Sales Quantity (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin, 2018-2023

Table 42. Orbusneich Company Profile and Main Business

Table 43. Orbusneich Recent Developments

Table 44. Promed Medical Company Information, Head Office, Market Area, and Industry Position

Table 45. Promed Medical Cardiovascular Drug-Eluting Stents(DES) Models, Specifications, and Application

Table 46. Promed Medical Cardiovascular Drug-Eluting Stents(DES) Sales Quantity (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin, 2018-2023

Table 47. Promed Medical Company Profile and Main Business

Table 48. Promed Medical Recent Developments

Table 49. Relisys Medical Company Information, Head Office, Market Area, and Industry Position

Table 50. Relisys Medical Cardiovascular Drug-Eluting Stents(DES) Models, Specifications, and Application

Table 51. Relisys Medical Cardiovascular Drug-Eluting Stents(DES) Sales Quantity (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin, 2018-2023

Table 52. Relisys Medical Company Profile and Main Business

Table 53. Relisys Medical Recent Developments

Table 54. Reva Medical Company Information, Head Office, Market Area, and Industry Position

Table 55. Reva Medical Cardiovascular Drug-Eluting Stents(DES) Models, Specifications, and Application

Table 56. Reva Medical Cardiovascular Drug-Eluting Stents(DES) Sales Quantity (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin, 2018-2023

Table 57. Reva Medical Company Profile and Main Business

Table 58. Reva Medical Recent Developments

Table 59. Sahajanand Company Information, Head Office, Market Area, and Industry Position

Table 60. Sahajanand Cardiovascular Drug-Eluting Stents(DES) Models, Specifications, and Application

Table 61. Sahajanand Cardiovascular Drug-Eluting Stents(DES) Sales Quantity (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin, 2018-2023

Table 62. Sahajanand Company Profile and Main Business

Table 63. Sahajanand Recent Developments

Table 64. Sino Medical Company Information, Head Office, Market Area, and Industry Position

Table 65. Sino Medical Cardiovascular Drug-Eluting Stents(DES) Models, Specifications, and Application

Table 66. Sino Medical Cardiovascular Drug-Eluting Stents(DES) Sales Quantity (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin, 2018-2023

Table 67. Sino Medical Company Profile and Main Business

Table 68. Sino Medical Recent Developments

Table 69. Sorin Company Information, Head Office, Market Area, and Industry Position

Table 70. Sorin Cardiovascular Drug-Eluting Stents(DES) Models, Specifications, and Application

Table 71. Sorin Cardiovascular Drug-Eluting Stents(DES) Sales Quantity (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin, 2018-2023

Table 72. Sorin Company Profile and Main Business

Table 73. Sorin Recent Developments

Table 74. Terumo Medical Company Information, Head Office, Market Area, and Industry Position

Table 75. Terumo Medical Cardiovascular Drug-Eluting Stents(DES) Models, Specifications, and Application

Table 76. Terumo Medical Cardiovascular Drug-Eluting Stents(DES) Sales Quantity (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin, 2018-2023

Table 77. Terumo Medical Company Profile and Main Business

Table 78. Terumo Medical Recent Developments

Table 79. Abbott Vascular Company Information, Head Office, Market Area, and Industry Position

Table 80. Abbott Vascular Cardiovascular Drug-Eluting Stents(DES) Models, Specifications, and Application

Table 81. Abbott Vascular Cardiovascular Drug-Eluting Stents(DES) Sales Quantity (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin, 2018-2023

Table 82. Abbott Vascular Company Profile and Main Business

Table 83. Abbott Vascular Recent Developments

Table 84. Advantec Vascular Company Information, Head Office, Market Area, and Industry Position

Table 85. Advantec Vascular Cardiovascular Drug-Eluting Stents(DES) Models, Specifications, and Application

Table 86. Advantec Vascular Cardiovascular Drug-Eluting Stents(DES) Sales Quantity (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin, 2018-2023

Table 87. Advantec Vascular Company Profile and Main Business

Table 88. Advantec Vascular Recent Developments

Table 89. B.Braun Melsengen AG Company Information, Head Office, Market Area, and Industry Position

Table 90. B.Braun Melsengen AG Cardiovascular Drug-Eluting Stents(DES) Models, Specifications, and Application

Table 91. B.Braun Melsengen AG Cardiovascular Drug-Eluting Stents(DES) Sales Quantity (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin, 2018-2023

Table 92. B.Braun Melsengen AG Company Profile and Main Business

Table 93. B.Braun Melsengen AG Recent Developments

Table 94. Biosensors Company Information, Head Office, Market Area, and Industry Position

Table 95. Biosensors Cardiovascular Drug-Eluting Stents(DES) Models, Specifications, and Application

Table 96. Biosensors Cardiovascular Drug-Eluting Stents(DES) Sales Quantity (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin, 2018-2023

Table 97. Biosensors Company Profile and Main Business

Table 98. Biosensors Recent Developments

Table 99. Boston Scientific Company Information, Head Office, Market Area, and Industry Position

Table 100. Boston Scientific Cardiovascular Drug-Eluting Stents(DES) Models, Specifications, and Application

Table 101. Boston Scientific Cardiovascular Drug-Eluting Stents(DES) Sales Quantity (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin, 2018-2023

Table 102. Boston Scientific Company Profile and Main Business

Table 103. Boston Scientific Recent Developments

Table 104. MicroPort Medical Company Information, Head Office, Market Area, and Industry Position

Table 105. MicroPort Medical Cardiovascular Drug-Eluting Stents(DES) Models, Specifications, and Application

Table 106. MicroPort Medical Cardiovascular Drug-Eluting Stents(DES) Sales Quantity (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin, 2018-2023

Table 107. MicroPort Medical Company Profile and Main Business

Table 108. MicroPort Medical Recent Developments

List of Figures

Figure 1. Cardiovascular Drug-Eluting Stents(DES) Picture

Figure 2. Global Cardiovascular Drug-Eluting Stents(DES) Consumption Value, (US$ million) & (2018-2029)

Figure 3. Global Cardiovascular Drug-Eluting Stents(DES) Sales Quantity, (K Units) & (2018-2029)

Figure 4. Global Cardiovascular Drug-Eluting Stents(DES) Average Selling Price (ASP), (2018-2029) & (US$/Unit)

Figure 5. China Cardiovascular Drug-Eluting Stents(DES) Consumption Value, (US$ million) & (2018-2029)

Figure 6. China Cardiovascular Drug-Eluting Stents(DES) Sales Quantity (K Units) & (2018-2029)

Figure 7. China Cardiovascular Drug-Eluting Stents(DES) Average Selling Price (ASP), (US$/Unit) & (2018-2029)

Figure 8. By Consumption Value, China Cardiovascular Drug-Eluting Stents(DES) Market Share of Global, 2018-2029

Figure 9. By Sales Quantity, China Cardiovascular Drug-Eluting Stents(DES) Market Share of Global, 2018-2029

Figure 10. Global Cardiovascular Drug-Eluting Stents(DES) Market Share by Company, (Tier 1, Tier 2, and Tier 3), 2022

Figure 11. China Cardiovascular Drug-Eluting Stents(DES) Key Participants, Market Share, 2022

Figure 12. Global Cardiovascular Drug-Eluting Stents(DES) Capacity, Production and Capacity Utilization, 2018-2029

Figure 13. Global Cardiovascular Drug-Eluting Stents(DES) Capacity Market Share by Region, 2022 VS 2029

Figure 14. Global Cardiovascular Drug-Eluting Stents(DES) Production Market Share & Forecast by Region, 2018-2029

Figure 15. Cardiovascular Drug-Eluting Stents(DES) Industry Chain

Figure 16. Cardiovascular Drug-Eluting Stents(DES) Procurement Model

Figure 17. Cardiovascular Drug-Eluting Stents(DES) Sales Model

Figure 18. Cardiovascular Drug-Eluting Stents(DES) Sales Channels, Direct Sales, and Distribution

Figure 19. Passive Coating

Figure 20. Active Coating

Figure 21. By Type, Global Cardiovascular Drug-Eluting Stents(DES) Consumption Value, 2018-2029, US$ Million

Figure 22. By Type, Global Cardiovascular Drug-Eluting Stents(DES) Consumption Value Market Share, 2018-2029

Figure 23. By Type, Global Cardiovascular Drug-Eluting Stents(DES) Sales Quantity, 2018-2029, (K Units)

Figure 24. By Type, Global Cardiovascular Drug-Eluting Stents(DES) Sales Quantity Market Share, 2018-2029

Figure 25. By Type, Global Cardiovascular Drug-Eluting Stents(DES) Average Selling Price (ASP), 2018-2029, (US$/Unit)

Figure 26. Hospital

Figure 27. Clinic

Figure 28. By Application, Global Cardiovascular Drug-Eluting Stents(DES) Consumption Value, 2018-2029, US$ Million

Figure 29. By Application, Global Cardiovascular Drug-Eluting Stents(DES) Consumption Value Market Share, 2018-2029

Figure 30. By Application, Global Cardiovascular Drug-Eluting Stents(DES) Sales Quantity, 2018-2029, (K Units)

Figure 31. By Application, Global Cardiovascular Drug-Eluting Stents(DES) Sales Quantity Market Share, 2018-2029

Figure 32. By Application, Global Cardiovascular Drug-Eluting Stents(DES) Average Selling Price (ASP), 2018-2029, (US$/Unit)

Figure 33. By Region, Global Cardiovascular Drug-Eluting Stents(DES) Consumption Value Market Share, 2018-2029

Figure 34. By Region, Global Cardiovascular Drug-Eluting Stents(DES) Sales Quantity Market Share, 2018-2029

Figure 35. North America Cardiovascular Drug-Eluting Stents(DES) Consumption Value & Forecasts, 2018-2029, US$ Million

Figure 36. By Country, North America Cardiovascular Drug-Eluting Stents(DES) Consumption Value Market Share, 2022

Figure 37. Europe Cardiovascular Drug-Eluting Stents(DES) Consumption Value & Forecasts, 2018-2029, US$ Million

Figure 38. By Country, Europe Cardiovascular Drug-Eluting Stents(DES) Consumption Value Market Share, 2022

Figure 39. Asia Pacific Cardiovascular Drug-Eluting Stents(DES) Consumption Value & Forecasts, 2018-2029, US$ Million

Figure 40. By Country/Region, Asia Pacific Cardiovascular Drug-Eluting Stents(DES) Consumption Value Market Share, 2022

Figure 41. South America Cardiovascular Drug-Eluting Stents(DES) Consumption Value & Forecasts, 2018-2029, US$ Million

Figure 42. By Country, South America Cardiovascular Drug-Eluting Stents(DES) Consumption Value Market Share, 2022

Figure 43. Middle East & Africa Cardiovascular Drug-Eluting Stents(DES) Consumption Value & Forecasts, 2018-2029, US$ Million

Figure 44. U.S. Cardiovascular Drug-Eluting Stents(DES) Sales Quantity, 2018-2029, (K Units)

Figure 45. By Type, U.S. Cardiovascular Drug-Eluting Stents(DES) Sales Quantity Market Share, 2022 VS 2029

Figure 46. By Application, U.S. Cardiovascular Drug-Eluting Stents(DES) Sales Quantity Market Share, 2022 VS 2029

Figure 47. Europe Cardiovascular Drug-Eluting Stents(DES) Sales Quantity, 2018-2029, (K Units)

Figure 48. By Type, Europe Cardiovascular Drug-Eluting Stents(DES) Sales Quantity Market Share, 2022 VS 2029

Figure 49. By Application, Europe Cardiovascular Drug-Eluting Stents(DES) Sales Quantity Market Share, 2022 VS 2029

Figure 50. China Cardiovascular Drug-Eluting Stents(DES) Sales Quantity, 2018-2029, (K Units)

Figure 51. By Type, China Cardiovascular Drug-Eluting Stents(DES) Sales Quantity Market Share, 2022 VS 2029

Figure 52. By Application, China Cardiovascular Drug-Eluting Stents(DES) Sales Quantity Market Share, 2022 VS 2029

Figure 53. Japan Cardiovascular Drug-Eluting Stents(DES) Sales Quantity, 2018-2029, (K Units)

Figure 54. By Type, Japan Cardiovascular Drug-Eluting Stents(DES) Sales Quantity Market Share, 2022 VS 2029

Figure 55. By Application, Japan Cardiovascular Drug-Eluting Stents(DES) Sales Quantity Market Share, 2022 VS 2029

Figure 56. South Korea Cardiovascular Drug-Eluting Stents(DES) Sales Quantity, 2018-2029, (K Units)

Figure 57. By Type, South Korea Cardiovascular Drug-Eluting Stents(DES) Sales Quantity Market Share, 2022 VS 2029

Figure 58. By Application, South Korea Cardiovascular Drug-Eluting Stents(DES) Sales Quantity Market Share, 2022 VS 2029

Figure 59. Southeast Asia Cardiovascular Drug-Eluting Stents(DES) Sales Quantity, 2018-2029, (K Units)

Figure 60. By Type, Southeast Asia Cardiovascular Drug-Eluting Stents(DES) Sales Quantity Market Share, 2022 VS 2029

Figure 61. By Application, Southeast Asia Cardiovascular Drug-Eluting Stents(DES) Sales Quantity Market Share, 2022 VS 2029

Figure 62. India Cardiovascular Drug-Eluting Stents(DES) Sales Quantity, 2018-2029, (K Units)

Figure 63. By Type, India Cardiovascular Drug-Eluting Stents(DES) Sales Quantity Market Share, 2022 VS 2029

Figure 64. By Application, India Cardiovascular Drug-Eluting Stents(DES) Sales Quantity Market Share, 2022 VS 2029

Figure 65. Middle East & Africa Cardiovascular Drug-Eluting Stents(DES) Sales Quantity, 2018-2029, (K Units)

Figure 66. By Type, Middle East & Africa Cardiovascular Drug-Eluting Stents(DES) Sales Quantity Market Share, 2022 VS 2029

Figure 67. By Application, Middle East & Africa Cardiovascular Drug-Eluting Stents(DES) Sales Quantity Market Share, 2022 VS 2029

Figure 68. Research Methodology

Figure 69. Breakdown of Primary Interviews

Figure 70. Bottom-up and Top-down Approaches

Figure 71. Top-down Approaches